Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Pasquale F, Innominato"'
Autor:
Pasquale F Innominato, Jamie H Macdonald, Wendy Saxton, Laura Longshaw, Rachel Granger, Iman Naja, Carlo Allocca, Ruth Edwards, Solah Rasheed, Frans Folkvord, Jordi de Batlle, Rohit Ail, Enrico Motta, Catherine Bale, Claire Fuller, Anna P Mullard, Christian P Subbe, Dawn Griffiths, Nicholas I Wreglesworth, Leandro Pecchia, Giuseppe Fico, Alessio Antonini
Publikováno v:
JMIR Research Protocols, Vol 13, p e52957 (2024)
BackgroundHealthy lifestyle interventions have a positive impact on multiple disease trajectories, including cancer-related outcomes. Specifically, appropriate habitual physical activity, adequate sleep, and a regular wholesome diet are of paramount
Externí odkaz:
https://doaj.org/article/e741d22a3f3d40538c2ffc0f1f493173
Autor:
Haydn Kissick, Viraj A Master, Mehmet A Bilen, Zachary S Buchwald, Mohammad K Khan, Caroline S Jansen, Michael C Lowe, Jimmy S Patel, Yena Woo, Amber Draper, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, David C Qian
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 3 (2024)
Background Recent studies have demonstrated that earlier time-of-day infusion of immune checkpoint inhibitors (ICIs) is associated with longer progression-free survival (PFS) and overall survival (OS) among patients with metastatic melanoma and non-s
Externí odkaz:
https://doaj.org/article/daa2d9d9173340d48a63f3613635074f
Autor:
Bethan R. Hughes, Sadiq Shanaz, Seline Ismail-Sutton, Nicholas I. Wreglesworth, Christian P. Subbe, Pasquale F. Innominato
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Immune Checkpoint Inhibitors (ICI) have revolutionised cancer care in recent years. Despite a global improvement in the efficacy and tolerability of systemic anticancer treatments, a sizeable proportion of patients still do not benefit maximally from
Externí odkaz:
https://doaj.org/article/ea844c4bdfd446989b7ee258fdbb0284
Autor:
Jordi de Batlle, Ivan D Benítez, Anna Moncusí-Moix, Odysseas Androutsos, Rosana Angles Barbastro, Alessio Antonini, Eunate Arana, Maria Fernanda Cabrera-Umpierrez, Gloria Cea, George Ε Dafoulas, Frans Folkvord, Ane Fullaondo, Francesco Giuliani, Hsiao-Ling Huang, Pasquale F Innominato, Przemyslaw Kardas, Vivian W Q Lou, Yannis Manios, Maria Matsangidou, Franco Mercalli, Mounir Mokhtari, Silvio Pagliara, Julia Schellong, Lisa Stieler, Konstantinos Votis, Paula Currás, Maria Teresa Arredondo, Jorge Posada, Sergio Guillén, Leandro Pecchia, Ferran Barbé, Gerard Torres, Giuseppe Fico
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e42187 (2023)
BackgroundThe World Health Organization’s strategy toward healthy aging fosters person-centered integrated care sustained by eHealth systems. However, there is a need for standardized frameworks or platforms accommodating and interconnecting multip
Externí odkaz:
https://doaj.org/article/7666b2129e434c49b474cd4eef328a4c
Autor:
Max Gibb MbChB, Hannah Winter CNS, Sandra Komarzynski Dipl Ing, MSc, Nicholas I. Wreglesworth MBBS, Pasquale F. Innominato MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 21 (2022)
The year 2022 could represent a significant juncture in the incorporation of mHealth solutions in routine cancer care. With the recent global COVID-19 pandemic leading a surge in both observation- and intervention-based studies predominantly aimed at
Externí odkaz:
https://doaj.org/article/2019c48b33e04d50b8f081a8a482556a
Autor:
Ayhan Ulusakarya, Abdoulaye Karaboué, Oriana Ciacio, Gabriella Pittau, Mazen Haydar, Pamela Biondani, Yusuf Gumus, Amale Chebib, Wathek Almohamad, Pasquale F. Innominato
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background FOLFIRINOX is a pillar first-line regimen in the treatment of pancreatic cancer. Historically, biliary tract cancer (BTC) and pancreatic cancer have been treated similarly with gemcitabine alone or combined with a platinum compoun
Externí odkaz:
https://doaj.org/article/106f8d63d58d4dc79620a2fe6773c833
Autor:
Pasquale F. Innominato, Annabelle Ballesta, Qi Huang, Christian Focan, Philippe Chollet, Abdoulaye Karaboué, Sylvie Giacchetti, Mohamed Bouchahda, René Adam, Carlo Garufi, Francis A. Lévi
Publikováno v:
Cancer Medicine, Vol 9, Iss 12, Pp 4148-4159 (2020)
Abstract The least toxic time (LTT) of irinotecan varied by up to 8 hours according to sex and genetic background in mice. The translational relevance was investigated within a randomized trial dataset, where no LTT stood out significantly in the who
Externí odkaz:
https://doaj.org/article/2990600537df42ceb50e3ef287e9b467
Publikováno v:
PLoS Computational Biology, Vol 16, Iss 1, p e1007218 (2020)
Precision medicine requires accurate technologies for drug administration and proper systems pharmacology approaches for patient data analysis. Here, plasma pharmacokinetics (PK) data of the OPTILIV trial in which cancer patients received oxaliplatin
Externí odkaz:
https://doaj.org/article/7784ee135eda414fb09d3a891895dd4b
Autor:
Pasquale F. Innominato, Sandra Komarzynski, Oxana G. Palesh, Robert Dallmann, Georg A. Bjarnason, Sylvie Giacchetti, Ayhan Ulusakarya, Mohamed Bouchahda, Mazen Haydar, Annabelle Ballesta, Abdoulaye Karaboué, Nicholas I. Wreglesworth, David Spiegel, Francis A. Lévi
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4396-4405 (2018)
Abstract Background Psychosocial symptoms often cluster together, are refractory to treatment, and impair health‐related quality of life (HR‐QoL) in cancer patients. The contribution of circadian rhythm alterations to systemic symptoms has been o
Externí odkaz:
https://doaj.org/article/e4e3a0683bbc487d80d05d53f77dea47
Autor:
Ayhan Ulusakarya, Sandra Komarzynski, David Spiegel, Robert Dallmann, Pasquale F. Innominato, Mohamed Bouchahda, Christian P Subbe, Abdoulaye Karaboué, Francis Lévi, Nicholas I Wreglesworth
Publikováno v:
Supportive Care in Cancer. 29:6167-6170
Background and aim\ud The evaluation of patient-reported outcomes (PRO) in cancer has proven relevant positive clinical impact on patients’ communication with healthcare professionals, decision-making for management, well-being, and overall surviva